Differences in hypothalamic type 2 deiodinase ubiquitination explain localized sensitivity to thyroxine
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
The current treatment for patients with hypothyroidism is levothyroxine (L-T4) along with normalization of serum thyroid-stimulating hormone (TSH). However, normalization of serum TSH with L-T4 monotherapy results in relatively low serum 3,5,3'-triiodothyronine (T3) and high serum thyroxine/T3 (T4/T3) ratio. In the hypothalamus-pituitary dyad as well as the rest of the brain, the majority of T3 present is generated locally by T4 deiodination via the type 2 deiodinase (D2); this pathway is self-limited by ubiquitination of D2 by the ubiquitin ligase WSB-1. Here, we determined that tissue-specific differences in D2 ubiquitination account for the high T4/T3 serum ratio in adult thyroidectomized (Tx) rats chronically implanted with subcutaneous L-T4 pellets. While L-T4 administration decreased whole-body D2-dependent T4 conversion to T3, D2 activity in the hypothalamus was only minimally affected by L-T4. In vivo studies in mice harboring an astrocyte-specific Wsb1 deletion as well as in vitro analysis of D2 ubiquitination driven by different tissue extracts indicated that D2 ubiquitination in the hypothalamus is relatively less. As a result, in contrast to other D2-expressing tissues, the hypothalamus is wired to have increased sensitivity to T4. These studies reveal that tissue-specific differences in D2 ubiquitination are an inherent property of the TRH/TSH feedback mechanism and indicate that only constant delivery of L-T4 and L-T3 fully normalizes T3-dependent metabolic markers and gene expression profiles in Tx rats.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The regulation varies by tissue as the brain predominantly expresses type 2 deiodinase, whereas type 1 deiodinase is abundant in other tissues of the body, and by thyroid state, as T3 excess upregulates type 1 deiodinase but downregulates type 2 deiodinase, which is upregulated in hypothyroidism (57–64).”
From Homeostatic control of the thyroid-pituitary axis: perspectives for diagnosis and treatment (2015) · cites this paper as [64]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The regulation varies by tissue as the brain predominantly expresses type 2 deiodinase, whereas type 1 deiodinase is abundant in other tissues of the body, and by thyroid state, as T3 excess upregulates type 1 deiodinase but downregulates type 2 deiodinase, which is upregulated in hypothyroidism (57–64).”
From Homeostatic control of the thyroid-pituitary axis: perspectives for diagnosis and treatment (2015) · cites this paper as [64]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Levothyroxine-treated hypothyroidism is also associated with reduced tri-iodothyronine signalling in the liver and brain.176”
From Hypothyroidism (2024) · cites this paper as [176]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Also in pituitary thyrotrophs, the loss of D2 activity caused by T4 is a much slower process [5].”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Finally, there is a new understanding that, under certain conditions, T3 signaling may be compromised in a tissue-specific fashion while systemic thyroid function is preserved.”
From Emerging Therapies in Hypothyroidism (2024) · cites this paper as [25]
Experimental — accuracy not yet measured
22 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Bianco, A. C., Salvatore, D., Gereben, B., Berry, M. J., & Larsen, P. R. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0455 · Cited by 1,853
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber, K. A. (2012) · Endocrine Practice · doi:10.4158/ep12280.gl · Cited by 1,567
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber for the American Association, K. A. (2012) · Thyroid · doi:10.1089/thy.2012.0205 · Cited by 1,053
Cellular and Molecular Basis of Deiodinase-Regulated Thyroid Hormone Signaling1
Gereben, B., Zavacki, A. M., Ribich, S., Kim, B. W., Huang, S. A., Simonides, W. S., Zeöld, A., & Bianco, A. C. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0019 · Cited by 891
Self-citationhGFAP‐cre transgenic mice for manipulation of glial and neuronal function in vivo
Zhuo, L., Theis, M., Alvarez‐Maya, I., Brenner, M., Willecke, K., & Messing, A. (2001) · genesis · doi:10.1002/gene.10008 · Cited by 659
Bacteriophage P1 site-specific recombination
Sternberg, N., & Hamilton, D. (1981) · Journal of Molecular Biology · doi:10.1016/0022-2836(81)90375-2 · Cited by 579
Ciechanover, A., Heller, H., Elias, S., Haas, A. L., & Hershko, A. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.3.1365 · Cited by 562
2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism
Wiersinga, W. M., Duntas, L., Fadeyev, V., Nygaard, B., & Vanderpump, M. P. J. (2012) · European Thyroid Journal · doi:10.1159/000339444 · Cited by 437
Research works printed but not linked: 3
- Bianco, 1988, Am J Physiol., 255, E496
- Tu, 1999, Endocrinology., 140, 784, 10.1210/endo.140.2.6486 · doi:10.1210/endo.140.2.6486 · Paper page
- Carvalho, 1993, Am J Physiol., 264, E874
Cited by
Items 101–184 of 184
Sun, H., Zhou, Y., Liu, J., Wang, Y., & Wang, G. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01188-6 · Cited by 9
Nie, X., Shen, Y., Ma, X., Xu, Y., Wang, Y., Zhou, J., & Bao, Y. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s236698 · Cited by 12
“Previous study has indicated that the hypothalamus-pituitary-thyroid axis is controlled by the DIO2-mediated conversion from FT4 to FT3 in hypothalamus.(30) The regulation of DIO2 is conserved and steady, and transducing minor change of the circulating FT4 levels.”
BackgroundTakahashi, S., Ito, M., Masaki, Y., Okazaki‐Hada, M., Minakata, M., Kohsaka, K., Nakamura, T., Kasahara, T., Kudo, T., Nishihara, E., et al. (2020) · Endocrine Journal · doi:10.1507/endocrj.ej20-0542 · Cited by 10
“In contrast, in periph‐ eral tissues, the relatively higher serum T4 levels could impair intracellular T3 production via downregulation of a D2 pathway [17].”
BackgroundSinha, P., Chakrabarti, N., Ghosh, N., Mitra, S., Dalui, S., & Bhattacharyya, A. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.12.013 · Cited by 9
Moli, R. L., Malandrino, P., Russo, M., Tumino, D., Piticchio, T., Naselli, A., Rapicavoli, V., Belfiore, A., & Frasca, F. (2023) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.406 · Cited by 9
Sun, Y. J., Teng, D., Zhao, L., Shi, X., Li, Y., Shan, Z., & Teng, W. (2022) · European Thyroid Journal · doi:10.1530/etj-21-0084 · Cited by 9
Mouse Models that Target Individual Selenoproteins
Conrad, M., & Schweizer, U. (2016) · Springer eBooks · doi:10.1007/978-3-319-41283-2_47 · Cited by 8
Role of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism
Jonklaas, J. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2021.12.003 · Cited by 10
Zamar, A. C., Kouimtsidis, C., Lulsegged, A., Roberts, R., Koutsomitros, T., & Stahl, D. R. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11195830 · Cited by 8
“Nineteen showed single nucleotide polymorphism (SNPs) in Deiodinase 1 (DiO1) and Deiodinase 2 (DiO2), and one showed SNPs in the SLCO1C1 protein carrier gene, which is associated with the intracellular transport and availability of thyroid hormones in the brain tissues as well as the periphery [16].”
BackgroundThe progression of secondary diabetes: A review of modeling studies
Yang, B., Li, J., Haller, M. J., Schatz, D. A., & Rong, L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1070979 · Cited by 6
Premawardhana, L. D., Taylor, P. N., Okosieme, O. E., Adlan, M. A., Obuobie, E. K., & Dayan, C. M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1282608 · Cited by 6
Bakos, B., Solymosi, T., Szili, B., Vincze, Á., Mészáros, S., Stempler, M., Armos, R., Kiss, A., Bakos, A., Szücs, N., et al. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-01962-9 · Cited by 8
“Results from animal studies [4] suggest that normalization of TSH does not necessarily signal appropriate T3 availability in all tissues.”
Martin, M., Subramaniyan, R., Naik, D., Ramamoorthy, L., & Lalthanthuami, H. T. (2023) · Journal of Family and Community Medicine · doi:10.4103/jfcm.jfcm_103_23 · Cited by 9
“[8,17] However, another study had shown that patients with hypothyroidism who had had replacement therapy reached normalized TSH values and had improved quality of life.”
Gökkaya, N., & Aydın, K. (2024) · Scientific Reports · doi:10.1038/s41598-024-78185-w · Cited by 8
“In some patients, this leads to insufficient T3 levels, higher fT4 levels, and a reduced T3/T4 ratio 26 .”
Can Iron Play a Crucial Role in Maintaining Cardiovascular Health in the 21st Century?
Szklarz, M., Gontarz-Nowak, K., Matuszewski, W., & Bandurska-Stankiewicz, E. M. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191911990 · Cited by 9
“In a study of pregnant women higher cortisol levels were seen in ID versus control subjects [239].”
BackgroundJonklaas, J. (2019) · Springer eBooks · doi:10.1007/978-3-319-72102-6_19 · Cited by 6
Shared Decisionmaking in the Treatment of Hypothyroidism
Bianco, A. C. (2025) · Clinical Endocrinology · doi:10.1111/cen.15228 · Cited by 7
Self-citationZamar, A., Robin, R., Alexander, B.-A., Lulsegged, A., & Kouimtsidis, C. (2021) · International Journal of Psychiatry Research · doi:10.33425/2641-4317.1091 · Cited by 5
“T3 production in the hypothalmo-pituitary glands is therefore, preserved relative to the peripheral circulation [32].”
BackgroundKasahara, T. (2025) · European Thyroid Journal · doi:10.1530/etj-24-0388 · Cited by 4
“…atrophy or athyreosis, factors such as individual variations in thyroid tissue volume, activity of type 2 deiodinase (D2) – an enzyme responsible for converting T4 to T3 – individual metabolic rates, and concurrent medications may affect T4-to-T3 conversion and serum FT3 levels (5, 12, 13, 14).”
The unique signature of tyrosine kinase inhibitor-induced hypothyroidism
Porcelli, T., Stefano, M. A. D., Luongo, C., Schlumberger, M. J., & Salvatore, D. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(25)00193-7 · Cited by 6
Penna, G., Guimarães, R. O., Benseñor, I. M., Ettleson, M. D., Pires, M. C., & Bianco, A. C. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.07.023 · Cited by 4
Self-citationMetabolic Consequences of Thyroidectomy and Patient-Centered Management
Wang, K., & Güleç, S. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13237465 · Cited by 7
Molnár, I., Szentmiklósi, J., & Somogyiné-Vári, É. (2017) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-113831 · Cited by 4
“The increased sensitivity to T4 in pituitary DII ubiquitination leads to accelerated DII inactivation with decreased local T3 production contributing to a discrepancy in TSH/TRH feedback [32].”
BackgroundAdvances in the Understanding of Genomic Links Between Thyroid Dysfunction and Psychiatric Disorders
Nygaard, B. (2022) · Thyroid · doi:10.1089/thy.2022.0686 · Cited by 4
“15 A meta-analysis of 18 clinical trials has not shown a consistent benefit of combination therapy with LT4 and lio-thyronine.”
Minakata, M., Ito, M., Kishi, T., Okazaki‐Hada, M., Masaki, Y., Nakamura, T., Kousaka, K., Kasahara, T., Kudo, T., Nishihara, E., et al. (2021) · Endocrine Journal · doi:10.1507/endocrj.ej21-0109 · Cited by 6
“Further, the presence of biochemical markers [19, 20] or symptoms [21] related to thyroid function studies in such patients indicate that patients with a low TSH have lower risks of developing hyperthyroid symptoms.”
BackgroundResultMehran, L., Amouzegar, A., Foroutan, S. M., Masoumi, S., Tohidi, M., Abdi, H., Aghaei, A., Saghafinia, A. E., & Azizi, F. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01434-y · Cited by 6
“…to what extent lower serum T3 levels may contribute to the persistent symptoms in hypothyroid patients; however, in an experimental study on thyroidectomized rats with evident tissue hypothyroidism in peripheral cells, tissue euthyroidism occurred only following normalization of serum T3 [11].”
BackgroundResultInfluentialPerros, P. (2018) · HORMONES · doi:10.1007/s42000-018-0068-7 · Cited by 7
Pharmacodynamic and Therapeutic Actions of Levothyroxine
Hennessey, J. V. (2021) · 70 Years of Levothyroxine · doi:10.1007/978-3-030-63277-9_3 · Cited by 4
Free triiodothyronine/free thyroxine ratio in children with congenital hypothyroidism
Sydlik, C., Dubinski, I., Bechtold, S. M., & Schmidt, H. (2022) · Endocrine Connections · doi:10.1530/ec-22-0032 · Cited by 3
Comparison of pathophysiology in subclinical hyperthyroidism with different etiologies
Deguchi-Horiuchi, H., Ito, M., Takahashi, S., Kousaka, K., Hisakado, M., Fukata, S., Kudo, T., Nishihara, E., Nishikawa, M., Miyauchi, A., et al. (2024) · Endocrine Journal · doi:10.1507/endocrj.ej23-0497 · Cited by 3
Selenium and Endocrine Tissues
Köhrle, J. (2016) · Springer eBooks · doi:10.1007/978-3-319-41283-2_33 · Cited by 6
Russo, M., Gullo, D., Tumino, D., Leonardi, D., Malandrino, P., & Frasca, F. (2022) · Clinical Endocrinology · doi:10.1111/cen.14738 · Cited by 3
We All Know We Need Them, We Hope They Are Coming, But When?
Bianco, A. C. (2020) · Thyroid · doi:10.1089/thy.2020.0250 · Cited by 3
“Thanks to its unique regulation, D2 faithfully informs the TRH and TSH secreting structures about the level of circulating T4 (6).”
BackgroundSelf-citationGoede, S. L., & Leow, M. K. (2024) · Acta Biotheoretica · doi:10.1007/s10441-024-09486-w · Cited by 2
“…direct interpretation of this figure, where [TRH] is presented as a [ The total effect on HPT control depends on the value of the intrinsic central nervous system (CNS) reference value for [FT3], which is indicated in the diagrams as R [FT3] (Werneck de Castro et al. 2015; Lechan and Fekete 2004).”
Ito, M., Deguchi-Horiuchi, H., Takahashi, S., Hisakado, M., Kohsaka, K., Nishihara, E., Fukata, S., Nishikawa, M., Miyauchi, A., & Akamizu, T. (2024) · Endocrine Journal · doi:10.1507/endocrj.ej24-0259 · Cited by 2
Hong, X., Yan, L., Sang, W., Liu, W., Li, Z.-T., Wang, J., Yan, S., Xin, J., Zhao, G.-F., Ma, X., et al. (2025) · Environmental Pollution · doi:10.1016/j.envpol.2025.126568 · Cited by 3
Liothyronine use in primary hypothyroidism — current concepts
Concepción‐Zavaleta, M. J., Ildefonso-Najarro, S. P., Paz‐Ibarra, J., Fernández-Dávila, F. V., Condori, D. C. D.-G., Rivera-Fabián, K., Herrera-Cabezas, R. G., & Urteaga, L. A. C. (2021) · Endokrynologia Polska · doi:10.5603/ep.a2021.0093 · Cited by 4
“Con - sistent with this, markers of euthyroidism, such as serum cholesterol levels, mitochondrial content, and enzymatic activity in liver and skeletal muscle, were closer to values in control rats when administration of LT4 and LT3 was sustained [25].”
Batistuzzo, A., Zhang, X., Bocco, B. M. L. C., McAninch, E. A., Salas-Lucia, F., Ribeiro, M. O., Arvan, P., Bianco, A. C., & Fonseca, T. L. (2025) · Endocrinology · doi:10.1210/endocr/bqaf046 · Cited by 1
Self-citationPorcelli, T., Luongo, C., Cerbone, A. M., Luccio, C. D., Stefano, M. A. D., & Salvatore, D. (2025) · Endocrine Related Cancer · doi:10.1530/erc-24-0323 · Cited by 2
Thyroid Hormone in Bone and Joint Disorders
Bassett, J. H. D., & Williams, G. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804182-6.00031-9 · Cited by 5
Oliveira, K. C., Laureano‐Melo, R., da Conceição, R. R., de Souza, J. S., Côrtes, W. D. S., Sato, M. A., Chiamolera, M. I., Maciel, R. M. B., & Giannocco, G. (2020) · HORMONES · doi:10.1007/s42000-020-00247-1 · Cited by 3
“For example, according to De Castro and coworkers [29], hypothalamic Dio2 is stable and fundamentally refractory to TH levels; consequently, the Dio2mediated T4-to-T3 conversion in the hypothalamus is not affected by hypothyroidism, hyperthyroidism, or administration of thyroid hormones.”
BackgroundTsanava, I. A., Bulgakova, S. V., & Melikova, A. V. (2021) · Russian Clinical Laboratory Diagnostics · doi:10.51620/0869-2084-2021-66-5-261-265 · Cited by 1
Is euthyroidism within reach for all?
Jonklaas, J. (2023) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2023.2267120 · Cited by 2
“The ‘holy grail’ of euthyroidism, however, is likely to be the perfect balance of thyroid hormones at a cellular level [9,10], which has been most thoroughly investigated in animal models [11,12].”
BackgroundOptimizing Levothyroxine Replacement in Primary Care Practice
Gunasekaran, K., & Tan, N. C. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1005906 · Cited by 3
A Genetically-Engineered Thyroid Gland Built for Selective Triiodothyronine Secretion
Citterio, C. E., Morales-Rodriguez, B., Liao, X.-H., Vu, C., Nguyen, R., Tsai, J., Le, J., Metawea, I., Liu, M., Olson, D. P., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157166 · Cited by 1
“The liver does not express D2 [56] and relies significantly on circulating T 3 [46,57].”
Role of T3 in Management of Hypothyroidism
Kalra, S., Mithal, A., WANGNOO, S. K., Seshadri, K., & Dharmalingnam, M. (2025) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_294_24 · Cited by 3
Advances in hypothyroidism management: rethinking therapy beyond levothyroxine
Ditshego, R., Pick, J., & Ncube, K. N. (2025) · SA pharmaceutical journal. · doi:10.36303/sapj.3267 · Cited by 1
Szabó, A., Farkas, S., Kádár, A., Török, B., Fazekas, C. L., Sipos, E., Bánrévi, K., Correia, P., Chaves, T., Kovács, T., et al. (2026) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2026.107839 · Cited by 1
Meneghini, V., Beltrão, F. E. D. L., Ismail, A., Hayek, S. S., Golovko, G., Khanipov, K., Ettleson, M. D., Benseñor, I. M., & Bianco, A. C. (2026) · Thyroid · doi:10.1177/10507256261460759 · Cited by 1
“34 Similar fi ndings were observed in the clinical setting.”
Self-citationQuality of life in hypothyroid subjects treated with levothyroxine: a cross-sectional study
Rezaeizade, H., Shabestari, M., Hazar, N., Ghadiri‐Anari, A., Mehrali, M., Salehi‐Shadkami, M., & Azizi, R. (2026) · Thyroid Research · doi:10.1186/s13044-026-00307-5 · Cited by 2
“This deficit was corrected when LT4 was combined with LT3 [23].”
Duntas, L. H. (2017) · Clinical and experimental thyroidology · doi:10.14341/ket2017314-19 · Cited by 23
“It is known that LT4 administration reduces wholebody D2-dependent T4 conversion to T3, though the effect of LT4 on D2 activity in the hypothalamus is minor [21].”
BackgroundNygaard, B. (2022) · doi:10.1093/med/9780198870197.003.0072 · Cited by 1
Clinical thyroidology: beyond the 1970s’ TSH-T4 Paradigm
Lindner, H. H. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1529791 · Cited by 2
Importance of Thyroid Hormone Replacement Therapy in Patients with Medullary Thyroid Cancer
Jonklaas, J. (2016) · Springer eBooks · doi:10.1007/978-3-319-39412-1_13 · Cited by 2
Ito, M., & Miyauchi, A. (2020) · Clinical Thyroidology · doi:10.1089/ct.2020;32.178-180 · Cited by 1
Objective Markers of Thyroid Hormone Homeostasis in Levothyroxine Versus Liothyronine Monotherapies
McAninch, E. A. (2022) · Clinical Thyroidology · doi:10.1089/ct.2022;34.389-391 · Cited by 1
Self-citationEndocrine Disorders: Integrative Treatments of Hypothyroidism, Diabetes, and Adrenal Dysfunction
Yang, J. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780190466268.003.0014
Derwahl, M. (2019) · Der Nuklearmediziner · doi:10.1055/a-0916-6665
“Auf zellulärer Ebene führen aber höhere T4-Spiegel zu einer Hemmung der Deiodinase 2 und damit der Konversion von T4 nach T3 [4].”
BackgroundTerapia sostitutiva tiroidea e risposta tissutale: quando il TSH non basta
Monzani, M. L., Piccinini, F., Simoni, M., & Brigante, G. (2020) · L Endocrinologo · doi:10.1007/s40619-020-00775-3
EXTENDED ABSORPTION OF LIOTHYRONINE FROM POLY-ZINC-LIOTHYRONINE (PZL) IN HUMANSPreprint
Dumitrescu, A. M., Hanlon, E. C., Arosemena, M., Duchon, O., Ettleson, M. D., Giurcanu, M. C., & Bianco, A. C. (2021) · medRxiv · doi:10.1101/2021.06.14.21258437
“In LT4-treated thyroidectomized rats, tissue euthyroidism only occurs after normalization of serum T3 (15).”
BackgroundSelf-citationThe pharmacological management of hypothyroidism
Moolman, L. J. (2021) · South African General Practitioner · doi:10.36303/sagp.2021.2.2.0070
Lee, S. Y. (2021) · Clinical Thyroidology · doi:10.1089/ct.2021;33.406-409
Diagnostica del nodulo tiroideo autonomo: è sufficiente misurare il TSH?
Campennì, A., Trimarchi, F., Chiovato, L., Siracusa, M., Ruggeri, R. M., & Giovanella, L. (2021) · L Endocrinologo · doi:10.1007/s40619-021-00982-6
“tre, variabile da individuo a individuo [25].”
64 脳卒中片麻痺における,音刺激後の片脚挙上動作反応時間と歩行能力の関連性(神経系理学療法IV)
福井, 瑞., 久保田, 健., 伊藤, 俊., & 隈元, 庸. (2005) · Journal of the Japanese Physical Therapy Association
New-Onset Heart Failure in the Setting of T4-Conversion Disorder
Chan, N. I., Pak, K., Guo, A., Singla, P., & Sayegh, M. N. (2022) · Cureus · doi:10.7759/cureus.25024 · Cited by 1
1. Key Notes in the Management of Thyroid Disorders
Akamizu, T. (2022) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.111.555
Atividade física e longevidade
Kitayama, C. (2023) · Revista Ciências da Saúde CEUMA · doi:10.61695/rcs.v1i1.11
Terapia dell’ipotiroidismo primitivo: un ormone o due ormoni?
Brigante, G., Ceccarini, G., Porcelli, T., Santini, F., Salvatore, D., Simoni, M., & Bartalena, L. (2024) · L Endocrinologo · doi:10.1007/s40619-024-01429-4
“Uno studio più re-cente [14], anch’esso condotto su ratti tiroidectomizzati, ha dimostrato che la produzione globale di T3 da parte della D2 negli animali in monoterapia con L-T4 era ridotta del 20% rispetto ai controlli eutiroidei, e che la monoterapia con L-T4 si associava a un ridotto rapporto…”
Hoermann, R., & Dietrich, J. W. (2025) · Springer eBooks · doi:10.1007/978-981-96-3682-2_3
Hoermann, R., & Dietrich, J. W. (2025) · Springer eBooks · doi:10.1007/978-981-96-3682-2_11
Mechanisms of Health and Disease
Hoermann, R., & Dietrich, J. W. (2025) · Springer eBooks · doi:10.1007/978-981-96-3682-2_6
Precision Thyroid Hormone Therapy for Hypothyroidism
Bianco, A. C., & Beltrão, F. E. D. L. (2025) · Springer eBooks · doi:10.1007/978-3-031-89650-7_24
Self-citationZhai, P., Li, Q., Jiang, Y., Zhang, H., & Xing, C. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117433 · Cited by 3
Mehran, L., Amouzegar, A., Foroutan, S. M., Masoumi, S., Tohidi, M., Abdi, H., Aghaei, A., Saghafinia, A. E., & Azizi, F. (2024) · Figshare · doi:10.6084/m9.figshare.26613242
Sun, H., Zhou, Y., Liu, J., Wang, Y., & Wang, G. (2023) · Figshare · doi:10.6084/m9.figshare.24431987
Li, J., Moyd, S. A., & Zhang, Q. (2026) · Acta Physiologica · doi:10.1111/apha.70202
“…animal studies show compared with DIO2 in the cerebral cortex, hippocampus, and brown adipose tissues, where its ubiquitination is highly upregulated and thus its abundance/activity is downregulated by T4, DIO2 in the hypothalamus is poorly ubiquitinated and remains largely unresponsive to T4 [96].”
Rakhmatullov, R. F., Дементьева, Р. Е., Kondrateva, K. P., Евгеньевна, Ш. А., Rakhmatullov, F. K., Melnikova, L. V., & Shibaeva, T. M. (2026) · Consilium Medicum · doi:10.26442/20751753.2026.1.203567
Huang, Y. P., Quan, M., Wang, Q., Liang, J., Li, T., & Wang, W. (2026) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823261448583
Ito, M., Furumura, Y., Monno, I., Deguchi-Horiuchi, H., Imamura, C., Takahashi, S., Yamaoka, H., Hisakado, M., Kohsaka, K., Nishihara, E., et al. (2026) · Thyroid Research · doi:10.1186/s13044-026-00300-y
“FT 3 is a biologically active hormone that provides a more accurate reflection of the thyroid function under these circumstances [7–9].”
Xue, B., Liu, Y., Wan, J., Tang, S., Shi, X., Cao, J., & Yuan, H. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1839913
Ohba, K., & Goto, Y. (2026) · Thyroid Science · doi:10.1016/j.thscie.2026.100048
Furumura, Y., Miyauchi, A., Ito, M., Nishikawa, M., Yamasaki, N., Iwayama, H., Iwasa, M., Yamamoto, M., Fujishima, M., Ito, Y., et al. (2026) · Thyroid · doi:10.1177/10507256261484710
“19,21,22 In the present study, rT3 was not correlated with TSH but was signi fi - cantly and positively correlated with fT4, raising the possibility that fT4-driven peripheral D2 ubiquitination may be involved.”
Athyreosis and Thyroid Hormone Signaling: A System-Based Framework for Long-Term Endocrine Health
Mazza, A. D. (2026) · Hormone and Metabolic Research · doi:10.1055/a-2969-5828
Metadata
- Authors
- Werneck de Castro, J. P., Fonseca, T. L., Ueta, C. B., McAninch, E. A., Abdalla, S., Wittmann, G., Lechan, R. M., Gereben, B., & Bianco, A. C.
- Affiliations
- Rush University Medical Center (US)
- University of Miami (US)
- Tufts University (US)
- Venue
- Journal of Clinical Investigation
- Published
- 2015-01-02
- Volume
- 125
- Issue
- 2
- Pages
- 769-781
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC4319436
- OpenAlex
- W2134856350
- Cited by
- 184
- References
- 62
- Citations by year
- 2026: 11 · 2025: 21 · 2024: 11 · 2023: 14 · 2022: 20 · 2021: 20 · 2020: 16 · 2019: 19 · 2018: 16 · 2017: 15 · 2016: 14 · 2015: 6
- FWCI
- 14.74
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK077148)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Keywords
- type 2 deiodinase, hypothalamus, triiodothyronine, T4/T3 ratio, levothyroxine, thyroidectomy, astrocytes, hypothyroidism treatment
- MeSH terms
- Iodothyronine Deiodinase Type II, Animals, Humans, Hypothalamo-Hypophyseal System, Hypothyroidism, Iodide Peroxidase, Thyrotropin, Thyroxine, Gene Expression Regulation, Enzymologic, Gene Deletion, Mice, Knockout, Ubiquitin-Protein Ligases, Intracellular Signaling Peptides and Proteins, Mice, Rats, Ubiquitination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.